Evidence map›Paper›PMID 37718447›Full record

ArticleBMC cancer2023

Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India.

Gh Rasool Bhat, Rajeshwer Singh Jamwal, Itty Sethi, Amrita Bhat, Ruchi Shah, Sonali Verma, Minerva Sharma, Hana Q Sadida, Sara K Al-Marzooqi, Tariq Masoodi and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Case report: GermlineFrontiers in oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Gh Rasool BhatSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India.
Rajeshwer Singh JamwalSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India.
Itty SethiInstitute of Human Genetics, University of Jammu, Jammu and Kashmir, 180001, India.
Amrita BhatInstitute of Human Genetics, University of Jammu, Jammu and Kashmir, 180001, India.
Ruchi ShahSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India.
Sonali VermaSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India.
Minerva SharmaSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India.
Hana Q SadidaDepartment of Human Genetics-Precision Medicine in Diabetes, Obesity & Cancer Program, Sidra Medicine, 26999, Doha, Qatar.
Sara K Al-MarzooqiDepartment of Human Genetics-Precision Medicine in Diabetes, Obesity & Cancer Program, Sidra Medicine, 26999, Doha, Qatar.
Tariq MasoodiLaboratory of Cancer Immunology and Genetics, Sidra Medicine, 26999, Doha, Qatar.
Sameer MirzaDepartment of Chemistry, College of Sciences, United Arab , Emirates University, 15551, Al-Ain, United Arab Emirates.
Mohammad HarisCenter for Advanced Metabolic Imaging in Precision Medicine, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Muzafar A MachaWatson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, 192122, Jammu and Kashmir, India.
Ammira S Alshabeeb AkilDepartment of Human Genetics-Precision Medicine in Diabetes, Obesity & Cancer Program, Sidra Medicine, 26999, Doha, Qatar.
Ajaz A BhatDepartment of Human Genetics-Precision Medicine in Diabetes, Obesity & Cancer Program, Sidra Medicine, 26999, Doha, Qatar. abhat@sidra.org.
Rakesh KumarSchool of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, 182320, India. kumar.rakesh@smvdu.ac.in.
Qatar Airways (Qatar) · QAShri Mata Vaishno Devi University · INIslamic University of Science and Technology · INUnited Arab Emirates University · AEUniversity of Jammu · INUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelomeres are repetitive DNA sequences located at the ends of chromosomes, playing a vital role in maintaining chromosomal integrity and stability. Dysregulation of telomeres has been implicated in the development of various cancers, including non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Genetic variations within telomere maintenance genes may influence the risk of developing NSCLC. The present study aimed to evaluate the genetic associations of select variants within telomere maintenance genes in a population from Jammu and Kashmir, North India, and to investigate the relationship between telomere length and NSCLC risk.

methodsWe employed the cost-effective and high-throughput MassARRAY MALDI-TOF platform to assess the genetic associations of select variants within telomere maintenance genes in a population from Jammu and Kashmir, North India. Additionally, we used TaqMan genotyping to validate our results. Furthermore, we investigated telomere length variation and its relation to NSCLC risk in the same population using dual-labeled fluorescence-based qPCR.

resultsOur findings revealed significant associations of TERT rs10069690 and POT1 rs10228682 with NSCLC risk (adjusted p-values = 0.019 and 0.002, respectively), while TERF2 rs251796 and rs2975843 showed no significant associations. The TaqMan genotyping validation further substantiated the associations of TERT rs10069690 and rs2242652 with NSCLC risk (adjusted p-values = 0.02 and 0.003, respectively). Our results also demonstrated significantly shorter telomere lengths in NSCLC patients compared to controls (p = 0.0004).

conclusionThis study highlights the crucial interplay between genetic variation in telomere maintenance genes, telomere attrition, and NSCLC risk in the Jammu and Kashmir population of North India. Our findings suggest that TERT and POT1 gene variants, along with telomere length, may serve as potential biomarkers and therapeutic targets for NSCLC in this population. Further research is warranted to elucidate the underlying mechanisms and to explore the potential clinical applications of these findings.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansIndiaMass SpectrometryTelomereBiomarker, Gene variantsNon-small cell lung cancerTelomere lengthTelomere maintenance gene

Identifiers

PMID37718447
PMCPMC10506276
OpenAlexW4386818339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.